Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-11

Clinical Trial Update: Vitamin D Nasal Drops in Post COVID-19 Parosmia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vitamin D nasal drops for post-COVID-19 parosmia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D nasal drops (vitamin D)

Snippet

Sponsor: Menoufia University | Conditions: Parosmia | Phase 2 | Status: UNKNOWN